Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael A Weber

Showing results (201-210 of 341) with videos related to

Pageof 35
Sort By:
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
Journal of Hypertension|June 15, 2007
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trialLuis M Ruilope, Alberto Zanchetti, Stevo Julius, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
Treatment of hypertension in patients with diabetes--an updateGeorge L Bakris, James R Sowers, Thomas D Glies, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
When and how to use self (home) and ambulatory blood pressure monitoringThomas G Pickering, William B White, Thomas D Giles, et al.
American Journal of Hypertension|September 15, 2004
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionKenneth A Jamerson, George L Bakris, Chuan-Chuan Wun, et al.
Journal of the National Medical Association|April 21, 2006
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyElizabeth O Ofili, Keith C Ferdinand, Elijah Saunders, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJoel M Neutel, Elijah Saunders, George L Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJames R Sowers, Joel M Neutel, Elijah Saunders, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
Journal of Hypertension|November 6, 2018
Nocturnal blood pressure measured by home devices: evidence and perspective for clinical applicationKei Asayama, Takeshi Fujiwara, Satoshi Hoshide, et al.
Pageof 35

Showing results (201-210 of 341) with videos related to

Sort By:
Pageof 35
Lancet (London, England)|December 11, 2012
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trialMichael A Weber, Kenneth Jamerson, George L Bakris, et al.
Journal of Hypertension|June 15, 2007
Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trialLuis M Ruilope, Alberto Zanchetti, Stevo Julius, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
Treatment of hypertension in patients with diabetes--an updateGeorge L Bakris, James R Sowers, Thomas D Glies, et al.
Journal of the American Society of Hypertension : JASH|April 20, 2010
When and how to use self (home) and ambulatory blood pressure monitoringThomas G Pickering, William B White, Thomas D Giles, et al.
American Journal of Hypertension|September 15, 2004
Rationale and design of the avoiding cardiovascular events through combination therapy in patients living with systolic hypertension (ACCOMPLISH) trial: the first randomized controlled trial to compare the clinical outcome effects of first-line combination therapies in hypertensionKenneth A Jamerson, George L Bakris, Chuan-Chuan Wun, et al.
Journal of the National Medical Association|April 21, 2006
Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapyElizabeth O Ofili, Keith C Ferdinand, Elijah Saunders, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 18, 2005
The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trialJoel M Neutel, Elijah Saunders, George L Bakris, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|July 20, 2006
Antihypertensive efficacy of Irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetesJames R Sowers, Joel M Neutel, Elijah Saunders, et al.
The New England Journal of Medicine|December 5, 2008
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patientsKenneth Jamerson, Michael A Weber, George L Bakris, et al.
Journal of Hypertension|November 6, 2018
Nocturnal blood pressure measured by home devices: evidence and perspective for clinical applicationKei Asayama, Takeshi Fujiwara, Satoshi Hoshide, et al.
Pageof 35